🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Clear Cell Renal Cell Carcinoma

The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma NCT07645690EARLY Phase 13 sites📍 Beijing📍 Beijing📍 Beijing Chinese PLA General Hospital · Tests: CLEAR CAR-T cell injection Autologous Dendritic Cell Vaccine in Kidney Cancer NCT05127824Phase 21 site📍 Pittsburgh Jodi Maranchie · Tests: Autologous alpha-DC1/TBVA vaccine, Cabozantinib Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial NCT03977571NA11 sites📍 Aarhus📍 Herlev📍 Odense Niels Fristrup · Tests: Cytoreductive nephrectomy, Tissue sampling Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma NCT06376669Phase 21 site📍 Washington D.C. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Proton Stereotactic Body Radiation therapy (SBRT) Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma NCT05830058Phase 22 sites📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Biospecimen Collection, Computed Tomography, Positron Emission Tomography, Questionnaire Administration, Stereotactic B… KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites📍 Phoenix📍 Tucson📍 Los Angeles Kura Oncology, Inc. · Tests: Darlifarnib, Cabozantinib, Adagrasib An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer NCT06447103Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Bone Scan, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors NCT07485114n/a1 site📍 Tel Aviv Daniel Keizman · Tests: Serum Gal-3 level, blood count and chemistry included liver function GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors NCT04977453Phase 1, Phase 213 sites📍 New York📍 New York📍 Huntersville GI Innovation, Inc. · Tests: GI-101, Pembrolizumab (KEYTRUDA®), Lenvatinib, GI-101A A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases NCT04299646Phase 230 sites📍 Albi📍 Angers📍 Bordeaux Centre Francois Baclesse · Tests: Steretactic radiotherapy Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT NCT05023265NA1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Stereotactic body radiotherapy 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients NCT05817903Phase 223 sites📍 Brescia📍 Candiolo📍 Catania Consorzio Oncotech · Tests: Axitinib, Nivolumab Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Immune Checkpoint Inhibitor A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 NCT07292168Phase 1, Phase 25 sites📍 Kazan'📍 Krasnoyarsk📍 Moscow Kidney Cancer Research Bureau · Tests: humanized monoclonal anti-FGFR1 antibody OM-RCA-01 An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07469683Phase 21 site📍 Seoul Yonsei University · Tests: SLC-3010 + Axitinib, Axitinib Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma NCT07234409NA1 site📍 Milan Niguarda Hospital · Tests: STANDARD FLANK APPROACH, Supine anterior retroperitoneal approach (SARA). Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC) NCT06005818Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Pembrolizumab injection Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors NCT04777994Phase 130 sites📍 Tucson📍 New Haven📍 Baltimore Calico Life Sciences LLC · Tests: ABBV-CLS-484, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI), Programmed Cell Deat… Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor NCT03093688Phase 1, Phase 21 site📍 Shanghai Shanghai Public Health Clinical Center · Tests: Infusion of iNKT cells and CD8+T cells A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma NCT07301827NA1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: [68Ga]Ga-DOTA-CAIX peptide, [68Ga]Ga-NOTA-CD70 antibody fragment, [68Ga]Ga-PSMA Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT NCT07166445n/a1 site📍 Beijing Peking University First Hospital · Tests: None intervention Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer NCT07128680Phase 12 sites📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Biospecimen Collection, Bone Scan, Computed Tomography, Faecalibacterium prausnitzii-containing Bacterial Strain Formul… CAIX-targeted PET/CT in Solid Tumors NCT07833085NA1 site📍 Wuhan Zhongnan Hospital · Tests: 68Ga-CAIX Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors NCT05856981Phase 17 sites📍 Detroit📍 St Louis📍 Canton Sairopa B.V. · Tests: ADU-1805, Pembrolizumab Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma NCT07011719Phase 3183 sites📍 Gilbert📍 Goodyear📍 Phoenix Arcus Biosciences, Inc. · Tests: Casdatifan, Cabozantinib, Placebo [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma NCT04989959Phase 11 site📍 Dallas Orhan Kemal Oz · Tests: [18F]PT2385, Positron Emission Tomography/Computed Tomography, Biopsy Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus NCT05969496Phase 23 sites📍 Aurora📍 Highlands Ranch📍 Lone Tree University of Colorado, Denver · Tests: Axitinib, Pembrolizumab Study of DCC-2812 in Participants With Advanced Genitourinary Cancers NCT06966024Phase 18 sites📍 Boston📍 Ann Arbor📍 St Louis Deciphera Pharmaceuticals, LLC · Tests: DCC-2812
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy